Optimal duration of DAPT a continued focus of research

02.09.20151965
Chief Medical Editor of Cardiology Today’s Intervention, discusses results of the OPTIDUAL Hot Line trial of dual antiplatelet therapy after drug-eluting stent implantation and provides his opinion on future research to determine the optimal duration of therapy in this population.

Thrombectomy improves neurological recovery after acute stroke

02.09.20151756
Use of thrombectomy to retrieve larger thrombi improved neurological recovery at discharge in patients with acute ischemic stroke, according to a substudy of the MR CLEAN trial.

Joint project of the RSC and ESC on webinars with Russian subtitles

31.08.20154907
RSC Board of Educational programmes together with European Society of Cardiology releases ESC webinars with Russian subtitles.

Renal function decline common in patients with AF prescribed anticoagulants

31.08.20151439
Deterioration of renal function, and an increase in related adverse events, may not be unusual in patients with nonvalvular atrial fibrillation prescribed nonvitamin K antagonist oral anticoagulants, according to recent study results in Heart and Vessels.

Five vital anticoagulation reads from the summer

28.08.20151914
Cardiology Today has compiled coverage of major anticoagulation research recently published in journals, offering clinicians an overview of where the field stands in the use and effects of various therapies to manage CVD.

HARMONY: Ranolazine, dronedarone combination benefits patients with paroxysmal AF

27.08.20151912
Published data from the HARMONY trial confirm a previous report that moderate-dose ranolazine plus reduced-dose dronedarone was well-tolerated and reduced atrial fibrillation burden, according to a report in Circulation: Arrhythmia & Electrophysiology.

Experts from RSC and Antihypertensive League created a brochure for medical practitioners that integrates the most used scales and lists of cardiological risks.

25.08.20152433
Experts from RSC and Antihypertensive League created a brochure for medical practitioners that integrates the most used scales and lists of cardiological risks.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.